Rifapin H junior Sachet

Product Overview

Product Form: Powder
Pack Size: 1x30's
Manufactured By: Schazoo Zaka (Pvt) Ltd
Prescription Required: Yes

Product Details

Rifapin-H Junior Powder Sachet contains a combination of Rifampcin 60mg and Isoniazid 30mg, two powerful anti-tubercular agents used in the treatment of tuberculosis. These sachets are designed for pediatric use, making it easier to administer the correct dosage for children.  helps to combat the infection by inhibiting the growth of tuberculosis bacteria and is a key component of multi-drug therapy for TB.

Purposes

The primary purpose of Rifapin-H Junior is to treat and prevent tuberculosis in children. It works by combining Rifampcin and Isoniazid, two essential drugs that inhibit the bacterial enzymes necessary for the bacteria's survival. This combination ensures effective treatment of tuberculosis and prevents the development of drug resistance when used correctly as part of a treatment plan.

Warnings

1. Hepatic Concerns: Prolonged use of Rifapin-H Junior may cause liver damage, especially in individuals with pre-existing liver conditions. Regular monitoring of liver function is essential during treatment.

2. Hypersensitivity: Some patients may experience allergic reactions to the ingredients in . Symptoms like rash, itching, or swelling should be reported to a healthcare provider immediately.

3. Discoloration: Rifampcin can cause discoloration of body fluids, including urine and tears, turning them a reddish-orange color. This is a harmless side effect but can be alarming if not expected.

Adverse Effects

The common adverse effects associated with Rifapin-H Junior Powder Sachet include nausea, vomiting, abdominal discomfort, and fatigue. In some cases, patients may experience peripheral neuropathy (tingling or numbness in the hands and feet) due to the Isoniazid component. It is recommended to take pyridoxine (Vitamin B6) to prevent this side effect.

Cautions

Children undergoing treatment with  should be regularly monitored for liver function and any signs of allergic reactions. Patients with a history of liver disease or alcohol use should consult their doctor before starting treatment. Ensure the complete course is followed to prevent the development of drug-resistant tuberculosis strains.